Chronic Exposure to Nicotine Enhances Insulin Sensitivity through α7 Nicotinic Acetylcholine Receptor-STAT3 Pathway

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Xu, Tian Ying ^a   Guo, Ling Ling ^a   Wang, Pei ^a   Song, Jie ^a   Le, Ying Ying ^b   Viollet, Benoit ^c,d   Miao, Chao Yu ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c INSTITUT COCHIN   (France)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 [[(4 METHYLPHENYL)SULFONYLOXY]ACETAMIDO]SALICYLIC ACID; 4 CHLORO N (3 QUINUCLIDINYL)BENZAMIDE; BUNGAROTOXIN RECEPTOR; GLUCOSE; HEXAMETHONIUM; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ALPHA2; INSULIN; NICOTINE; STAT3 PROTEIN; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; GLUCOSE TRANSPORT; INFLAMMATION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; KNOCKOUT MOUSE; LIVER; LONG TERM CARE; LONG TERM EXPOSURE; MALE; MOUSE; MYOTUBE; NONHUMAN; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WEIGHT REDUCTION;

ANIMALS; BLOTTING, WESTERN; GLUCOSE TOLERANCE TEST; INSULIN RESISTANCE; MALE; MICE; MICE, KNOCKOUT; NICOTINE; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR;

ANIMALIA; MUS; RATTUS;

EID: 84871253591     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051217     Document Type: Article

References (58)

1. Holland WL, Brozinick JT, Wang LP, Hawkins ED, Sargent KM, et al. (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5: 167-179.
2. DeFronzo RA, (2010) Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 53: 1270-1287.
3. Bodmer M, Meier C, Krahenbuhl S, Jick SS, Meier CR, (2010) Long-term metformin use is associated with decreased risk of breast cancer. Diabetes Care 33: 1304-1308.
4. Faulds MH, Dahlman-Wright K, (2012) Metabolic diseases and cancer risk. Curr Opin Oncol 24: 58-61.
5. Jiang M, Jerome WG, Hayward SW, (2010) Autophagy in nuclear receptor PPARgamma-deficient mouse prostatic carcinogenesis. Autophagy 6: 175-176.
6. Psaty BM, Furberg CD, (2007) Rosiglitazone and cardiovascular risk. N Engl J Med 356: 2522-2524.
7. Orrico KB, Lin JK, Wei A, Yue H, (2010) Clinical consequences of disseminating the rosiglitazone FDA safety warning. Am J Manag Care 16: e111-116.
8. Graham DJ, Ouellet-Hellstrom R, MaCurdy TE, Ali F, Sholley C, et al. (2010) Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone. Jama 304: 411-418.
9. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J, (2007) Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. Jama 298: 2654-2664.
10. Axelsson T, Jansson PA, Smith U, Eliasson B, (2001) Nicotine infusion acutely impairs insulin sensitivity in type 2 diabetic patients but not in healthy subjects. J Intern Med 249: 539-544.
11. Morgan TM, Crawford L, Stoller A, Toth D, Yeo KT, et al. (2004) Acute effects of nicotine on serum glucose insulin growth hormone and cortisol in healthy smokers. Metabolism 53: 578-582.
12. Eliasson B, Taskinen MR, Smith U, (1996) Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation 94: 878-881.
13. Assali AR, Beigel Y, Schreibman R, Shafer Z, Fainaru M, (1999) Weight gain and insulin resistance during nicotine replacement therapy. Clin Cardiol 22: 357-360.
14. Liu RH, Mizuta M, Matsukura S, (2003) Long-term oral nicotine administration reduces insulin resistance in obese rats. Eur J Pharmacol 458: 227-234.
15. Liu RH, Mizuta M, Matsukura S, (2004) The expression and functional role of nicotinic acetylcholine receptors in rat adipocytes. J Pharmacol Exp Ther 310: 52-58.
16. Lan XH, Xu TY, Miao CY, (2008) Establishment and evaluation of a nicotine-treatment and- withdrawal rat model. AJSMMU 29: 156-161.
17. Liu C, Shen FM, Le YY, Kong Y, Liu X, et al. (2009) Antishock effect of anisodamine involves a novel pathway for activating alpha7 nicotinic acetylcholine receptor. Crit Care Med 37: 634-641.
18. Wang P, Xu TY, Guan YF, Tian WW, Viollet B, et al. (2011) Nicotinamide phosphoribosyltransferase protects against ischemic stroke through SIRT1-dependent adenosine monophosphate-activated kinase pathway. Ann Neurol 69: 360-374.
19. Wang P, Zhang RY, Song J, Guan YF, Xu TY, et al. (2012) Loss of AMP-activated protein kinase-alpha2 impairs the insulin-sensitizing effect of calorie restriction in skeletal muscle. Diabetes 61: 1051-1061.
20. Li DJ, Evans RG, Yang ZW, Song SW, Wang P, et al. (2011) Dysfunction of the cholinergic anti-inflammatory pathway mediates organ damage in hypertension. Hypertension 57: 298-307.
21. Waring JF, Abel S, Li J, Bitner RS, Nikkel AL, et al. (2008) Analysis of gene expression profiles in rat hippocampus following treatment with nicotine and an alpha7 nAChR selective agonist. Neurosci Res 60: 266-274.
22. Beck Jorgensen S, O'Neill HM, Hewitt K, Kemp BE, Steinberg GR, (2009) Reduced AMP-activated protein kinase activity in mouse skeletal muscle does not exacerbate the development of insulin resistance with obesity. Diabetologia 52: 2395-2404.
23. Sassmann A, Gier B, Grone HJ, Drews G, Offermanns S, et al. (2010) The Gq/G11-mediated signaling pathway is critical for autocrine potentiation of insulin secretion in mice. J Clin Invest 120: 2184-2193.
24. Strader AD, Vahl TP, Jandacek RJ, Woods SC, D'Alessio DA, et al. (2005) Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats. Am J Physiol Endocrinol Metab 288: E447-453.
25. Gasparetti AL, de Souza CT, Pereira-da-Silva M, Oliveira RL, Saad MJ, et al. (2003) Cold exposure induces tissue-specific modulation of the insulin-signalling pathway in Rattus norvegicus. J Physiol 552: 149-162.
26. Rowe GC, Jang C, Patten IS, Arany Z, (2011) PGC-1beta regulates angiogenesis in skeletal muscle. Am J Physiol Endocrinol Metab 301: E155-163.
27. Zhong L, D'Urso A, Toiber D, Sebastian C, Henry RE, et al. (2010) The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell 140: 280-293.
28. Yan J, Yang H, Wang G, Sun L, Zhou Y, et al. (2010) Autophagy augmented by troglitazone is independent of EGFR transactivation and correlated with AMP-activated protein kinase signaling. Autophagy 6: 67-73.
29. Wang P, Guan YF, Du H, Zhai QW, Su DF, et al. (2012) Induction of autophagy contributes to the neuroprotection of nicotinamide phosphoribosyltransferase in cerebral ischemia. Autophagy 8: 77-87.
30. Szwaya J, Bruseo C, Nakuci E, McSweeney D, Xiang X, et al. (2007) A novel platform for accelerated pharmacodynamic profiling for lead optimization of anticancer drug candidates. J Biomol Screen 12: 159-166.
31. Xu TY, Chen RH, Wang P, Zhang RY, Ke SF, et al. (2010) 4-Phenyl butyric acid does not generally reduce glucose levels in rodent models of diabetes. Clin Exp Pharmacol Physiol 37: 441-446.
32. Wang P, Du H, Zhang RY, Guan YF, Xu TY, et al. (2010) Circulating and local visfatin/Nampt/PBEF levels in spontaneously hypertensive rats, stroke-prone spontaneously hypertensive rats and Wistar-Kyoto rats. J Physiol Sci 60: 317-324.
33. Cacho J, Sevillano J, de Castro J, Herrera E, Ramos MP, (2008) Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats. Am J Physiol Endocrinol Metab 295: E1269-1276.
34. Wada T, Naito M, Kenmochi H, Tsuneki H, Sasaoka T, (2007) Chronic nicotine exposure enhances insulin-induced mitogenic signaling via up-regulation of alpha7 nicotinic receptors in isolated rat aortic smooth muscle cells. Endocrinology 148: 790-799.
35. Bertrand D, Bertrand S, Ballivet M, (1992) Pharmacological properties of the homomeric alpha 7 receptor. Neurosci Lett 146: 87-90.
36. Levine RR, (1960) The physiological disposition of hexamethonium and related compounds. J Pharmacol Exp Ther 129: 296-304.
37. Viollet B, Lantier L, Devin-Leclerc J, Hebrard S, Amouyal C, et al. (2009) Targeting the AMPK pathway for the treatment of Type 2 diabetes. Front Biosci 14: 3380-3400.
38. Winder WW, (2008) Can patients with type 2 diabetes be treated with 5′-AMP-activated protein kinase activators? Diabetologia 51: 1761-1764.
39. Moh A, Zhang W, Yu S, Wang J, Xu X, et al. (2008) STAT3 sensitizes insulin signaling by negatively regulating glycogen synthase kinase-3 beta. Diabetes 57: 1227-1235.
40. Koch L, Wunderlich FT, Seibler J, Konner AC, Hampel B, et al. (2008) Central insulin action regulates peripheral glucose and fat metabolism in mice. J Clin Invest 118: 2132-2147.
41. Mantzoros CS, Magkos F, Brinkoetter M, Sienkiewicz E, Dardeno TA, et al. (2011) Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab 301: E567-584.
42. Viollet B, Andreelli F, Jorgensen SB, Perrin C, Geloen A, et al. (2003) The AMP-activated protein kinase alpha2 catalytic subunit controls whole-body insulin sensitivity. J Clin Invest 111: 91-98.
43. Viollet B, Andreelli F, Jorgensen SB, Perrin C, Flamez D, et al. (2003) Physiological role of AMP-activated protein kinase (AMPK): insights from knockout mouse models. Biochem Soc Trans 31: 216-219.
44. Wang X, Yang Z, Xue B, Shi H, (2011) Activation of the cholinergic antiinflammatory pathway ameliorates obesity-induced inflammation and insulin resistance. Endocrinology 152: 836-846.
45. Swislocki AL, (2003) Smokeless nicotine administration does not result in hypertension or a deterioration in glucose tolerance or insulin sensitivity in juvenile rats. Metabolism 52: 67-72.
46. Swislocki AL, Tsuzuki A, Tait M, Khuu D, Fann K, (1997) Smokeless nicotine administration is associated with hypertension but not with a deterioration in glucose tolerance in rats. Metabolism 46: 1008-1012.
47. Benowitz NL, Henningfield JE, (1994) Establishing a nicotine threshold for addiction. The implications for tobacco regulation. N Engl J Med 331: 123-125.
48. Gahring LC, Rogers SW, (2006) Neuronal nicotinic acetylcholine receptor expression and function on nonneuronal cells. Aaps J 7: E885-894.
49. Mineur YS, Abizaid A, Rao Y, Salas R, DiLeone RJ, et al. (2011) Nicotine decreases food intake through activation of POMC neurons. Science 332: 1330-1332.
50. Wang P, Yang FJ, Du H, Guan YF, Xu TY, et al. (2011) Involvement of leptin receptor long isoform (LepRb)-STAT3 signaling pathway in brain fat mass- and obesity-associated (FTO) downregulation during energy restriction. Mol Med 17: 523-532.
51. Perkins KA, Epstein LH, Marks BL, Stiller RL, Jacob RG, (1989) The effect of nicotine on energy expenditure during light physical activity. N Engl J Med 320: 898-903.
52. Yoshida T, Sakane N, Umekawa T, Kogure A, Kondo M, et al. (1999) Nicotine induces uncoupling protein 1 in white adipose tissue of obese mice. Int J Obes Relat Metab Disord 23: 570-575.
53. Marrero MB, Lucas R, Salet C, Hauser TA, Mazurov A, et al. (2010) An alpha7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes. J Pharmacol Exp Ther 332: 173-180.
54. Taniguchi CM, Emanuelli B, Kahn CR, (2006) Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 7: 85-96.
55. Pavlov VA, (2008) Cholinergic modulation of inflammation. Int J Clin Exp Med 1: 203-212.
56. Yu JG, Zhou RR, Cai GJ, (2011) From hypertension to stroke: mechanisms and potential prevention strategies. CNS Neurosci Ther 17: 577-584.
57. Echeverria V, Zeitlin R, (2012) Cotinine: a potential new therapeutic agent against Alzheimer's disease. CNS Neurosci Ther 18: 517-523.
58. Wang P, Tian WW, Song J, Guan YF, Miao CY, (2011) Deficiency of NG2+ cells contributes to the susceptibility of stroke-prone spontaneously hypertensive rats. CNS Neurosci Ther 17: 327-332.